Animals exposed to the CXCR3 antagonist indeed had slower tumor growth than control animals with an intact CXCR3 chemokine axis, supporting the conclusion that antagonism of CXCR3 inhibits tumor growth. The gene discussed is CXCR3; the disease is neoplasm.